News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,181 Results
Type
Article (5013)
Company Profile (17)
Press Release (220151)
Section
Business (82200)
Career Advice (461)
Deals (15043)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3677)
Job Trends (3901)
News (120106)
Policy (7501)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14772)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3694)
Artificial intelligence (41)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (446)
Cardiovascular disease (24)
Career advice (393)
Career pathing (3)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16029)
Collaboration (169)
Compensation (169)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (104)
Cystic fibrosis (16)
Data (512)
Depression (5)
Diabetes (42)
Diagnostics (2042)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40821)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37766)
Executive appointments (311)
FDA (3928)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (108)
Government (411)
Guidances (17)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7822)
IRA (3)
Job creations (1121)
Job search strategy (360)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (54)
Lymphoma (31)
Management (10)
Manufacturing (49)
MASH (28)
Medical device (3859)
Medtech (3860)
Mergers & acquisitions (7426)
Metabolic disorders (122)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (340)
NextGen: Class of 2025 (1674)
Non-profit (727)
Northern California (927)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (27)
Partnered (4)
Patents (21)
Patient recruitment (29)
Peanut (5)
People (24588)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4777)
Phase II (6961)
Phase III (5548)
Pipeline (552)
Policy (9)
Postmarket research (625)
Preclinical (1869)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (67)
Real estate (1874)
Recruiting (8)
Regulatory (5113)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Southern California (700)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1008)
Stomach cancer (1)
Supply chain (10)
Tariffs (4)
United States (7032)
Vaccines (36)
Venture capitalists (2)
Weight loss (21)
Women's health (1)
Date
Last 7 days (174)
Last 30 days (653)
Last 365 days (9948)
2025 (2994)
2024 (11027)
2023 (13194)
2022 (18659)
2021 (19679)
2020 (18239)
2019 (13205)
2018 (10205)
2017 (10002)
2016 (9157)
2015 (12118)
2014 (9588)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11453)
Australia (1608)
California (1943)
Canada (698)
China (71)
Colorado (82)
Connecticut (91)
Delaware (29)
Europe (24511)
Florida (275)
Georgia (33)
Idaho (23)
Illinois (112)
India (7)
Indiana (64)
Iowa (2)
Japan (72)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (221)
Massachusetts (1552)
Michigan (85)
Minnesota (139)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (558)
New Mexico (5)
New York (470)
North Carolina (327)
North Dakota (2)
Northern California (927)
Ohio (56)
Oklahoma (5)
Oregon (4)
Pennsylvania (346)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (5)
Southern California (700)
Tennessee (40)
Texas (228)
Utah (60)
Virginia (46)
Washington D.C. (9)
Washington State (174)
West Virginia (2)
Wisconsin (22)
225,181 Results for "digirad corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
TTG Imaging Solutions Acquires Digirad Health from Star Equity Holdings
TTG Imaging Solutions, LLC announced the acquisition of Digirad Health, Inc., headquartered in Suwanee, GA. The acquisition closed on May 4, 2023.
May 5, 2023
·
3 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
BioMidwest
Digirad Corporation Changes Corporate Name to Star Equity Holdings, Inc.
Digirad Corporation, a diversified holding company with three divisions: Healthcare, Building & Construction, and Real Estate & Investments, announced that it has changed its corporate name to Star Equity Holdings, Inc. with an effective date of January 1, 2021.
December 28, 2020
·
9 min read
Digirad Corporation to Present at Investor Conferences in November
Digirad Corporation (Nasdaq: DRAD; DRADP) (“Digirad” or the “Company”), a diversified holding company with three divisions: Healthcare, Building & Construction, and Real Estate & Investments, today announced that its management team will participate at the following investors conferences: November 17: Craig-Hallum Alpha Select Virtual Conference November 18: The Benchmark Company Discovery One on One Virtual Investor Conference Digi
November 13, 2020
·
7 min read
Business
Digirad Corporation to Release Second Quarter 2020 Financial Results on August 13
Digirad Corporation (Nasdaq: DRAD; DRADP) (“Digirad” or the “Company”) will release its financial results for the second quarter ended June 30, 2020, before the market opens on Thursday, August 13, 2020.
August 7, 2020
·
7 min read
Press Releases
Quantum BioPharma Corporate Update
April 21, 2025
·
4 min read
Business
Digirad Corporation to Release Third Quarter 2020 Financial Results on November 13
Digirad Corporation (Nasdaq: DRAD; DRADP) (“Digirad” or the “Company”), a diversified holding company with three divisions: Healthcare, Building & Construction, and Real Estate & Investments, will release its financial results for the third quarter ended September 30, 2020, before the market opens on Friday, November 13, 2020.
November 6, 2020
·
7 min read
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
·
2 min read
Digirad Corporation to Present at the LD 500 Virtual Conference on September 1st
Digirad Corporation (NASDAQ:DRAD; DRADP) (“Digirad” or the “Company”), a diversified holding company with three divisions: Healthcare, Building & Construction, and Real Estate & Investments, today announced that its management team will be presenting at the LD 500 Virtual Conference, on Tuesday, September 1
August 25, 2020
·
8 min read
Digirad Corporation to Present at the Sidoti Virtual Microcap Conference on June 30th
Digirad Corporation (Nasdaq: DRAD; DRADP) (“Digirad” or the “Company”), a diversified holding company with three divisions: Healthcare, Building & Construction, and Real Estate & Investments, today announced that its management team will be presenting at the Sidoti Inaugural Virtual Microcap Conference, on Tuesday, June 30 th . Digirad’s main presentation is scheduled for 12:15 pm ET, in Virtual Estate Room #1. Investors will be able t
June 24, 2020
·
7 min read
1 of 22,519
Next
